0001846487-24-000002.txt : 20240216
0001846487-24-000002.hdr.sgml : 20240216
20240216165042
ACCESSION NUMBER: 0001846487-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mutz Christopher
CENTRAL INDEX KEY: 0001846487
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31812
FILM NUMBER: 24649143
MAIL ADDRESS:
STREET 1: C/O ANI PHARMACEUTICALS, INC.
STREET 2: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001023024
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 582301143
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
BUSINESS PHONE: 2186343500
MAIL ADDRESS:
STREET 1: 210 MAIN STREET WEST
CITY: BAUDETTE
STATE: MN
ZIP: 56623
FORMER COMPANY:
FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19991228
FORMER COMPANY:
FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991027
4
1
wk-form4_1708120221.xml
FORM 4
X0508
4
2024-02-14
0
0001023024
ANI PHARMACEUTICALS INC
ANIP
0001846487
Mutz Christopher
C/O ANI PHARMACEUTICALS, INC.
210 MAIN STREET WEST
BAUDETTE
MN
56623
0
1
0
0
HEAD OF RARE DISEASE
0
Common Stock
2024-02-14
4
A
0
18790
0
A
82397
D
Common Stock
2024-02-14
4
A
0
12526
0
A
94923
D
Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024.
These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
/s/ Christopher Mutz, by attorney-in-fact Meredith W. Cook
2024-02-16